Trial intelligence / Profile preview

COCP for Bleeding in Etonogestrel Implant Users

NCT01968135Phase 2Completed

Sponsor
University of Colorado Denver
Start
Oct 2013
Primary completion
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of avatrombopag, ethinyl estradiol in Abnormal uterine bleeding (AUB), sponsored by University of Colorado Denver. Started Oct 2013; status: completed.

02

Drugs

avatrombopagethinyl estradiol
03

Conditions

Abnormal uterine bleeding (AUB)

Beyond the preview

Go deeper on NCT01968135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01968135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call